Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Digital Psychotherapeutics Market

Digital Psychotherapeutics Market Size

  • Report ID: GMI7175
  • Published Date: Oct 2023
  • Report Format: PDF

Digital Psychotherapeutics Market Size

Digital Psychotherapeutics Market size was valued at around USD 1.2 billion in 2022 and is estimated to account over USD 16.9 billion by 2032. The prevalence of psychological disorders such as depression, anxiety, and stress-related ailments is rising globally. The increased prevalence of psychological disorders is boosting the demand for accessible and effective treatment choices, thus, fueling the expansion of digital psychotherapeutics.


Digital Psychotherapeutics Market

To understand key trends  
Download Free Sample

For instance, according to Australian Bureau of Statistics, in 2022, 21.5% of people had a 12-month mental disorder, with anxiety being the most common group (17.2% of people aged 16–85 years). In addition, according to World Health Organisation (WHO) fact sheet 2022, 1 out of every 8 individuals in this world suffers from a psychological disorder. Moreover, growing awareness of mental health concerns has reduced stigma and increased individuals' willingness to seek treatment. Individuals are becoming more self-aware of their mental health, that has substantially increased the demand for digital psychotherapeutics.


Digital psychotherapeutics are evidence-based therapy treatments and services given through digital technology and software applications. These treatments are intended to test, cure, or aid people suffering from a variety of psychological conditions, such as depression, anxiety, stress, and mood disorders.


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Digital psychotherapeutics industry reached around USD 1.2 billion in revenue in 2022 and is projected to be worth USD 16.9 billion by 2032 owing to the rising prevalence of psychological disorders and the surging demand for accessible and effective treatment choices.

The combination therapy segment generated USD 836 million in 2022 and is estimated to witness high demand through 2032 attributed to its improved treatment efficacy.

North America digital psychotherapeutics industry amassed USD 700.3 million in revenue in 2022 and is set to witness robust growth through 2032 with the increasing mental health awareness and the growing recognition of the importance of mental well-being in the region.

The competitive landscape of the digital psychotherapeutics industry includes prominent firms, such as Novartis AG, Pear Therapeutics, SilverCloud Health, Woebot Health, Starling Minds, SwissDT, AbleTo, Inc., Spring Care, Inc, Meru, and Ginger.

Digital Psychotherapeutics Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 264
  • Countries covered: 22
  • Pages: 160
 Download Free Sample